Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
Unique classification system to reduce the number of drugs taken by elderly patients
Illustrated with helpful diagrams and tables
With people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As aging people often suffer from several chronic diseases and are being treated with multiple medications concurrently, unwanted drug interactions occur more frequently.
Whereas recent approaches have recommended to remove particular drugs from the medication regimen to avoid adverse effects, DrugTherapy for the Elderly underlines both indispensable and dispensable elements of drug treatment, providing the practitioner with: - Background information on the elderly population regarding their needs for particular drugs (with an eye to frailty, co-morbidity patterns, and special sensitivities regarding drug metabolism and excretion) - Practical advice about drug treatment surveillance parameters in the elderly - In-depth discussion of drugs in relation to the elderly with specific diagnoses - Integration of multimorbidity/polypharmacy situations into prioritization schemes - A plan for how to deal with the complexity of polypharmacy situations in a five-minute consultation
An original classification of drugs is proposed by the editor which relates the power of effects, prognostic data, and tolerability to a prioritization scoring system. This approach is the first to not only provide a negative listing, but also integrates positive data into an overall assessment for drugs fit for the aged. Therefore, Drug Therapy for the Elderly serves as a timely reference for a wide array of physicians.